Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- CheckyesterdayChange DetectedThe page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.SummaryDifference0.0%
- Check8 days agoChange DetectedThe web page has been updated to reflect an increase in study locations from 39 to 40, with several new principal investigators and their contact information added, while some previous locations and contacts have been removed. Additionally, the status of some locations has changed from 'Active, not recruiting' to 'Recruiting'.SummaryDifference10%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed historical context about the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry and the addition of new information regarding sample collection and collaborators. The revision number has also been updated.SummaryDifference29%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 19, 2024.SummaryDifference0.4%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous estimated update date of December 19, 2024.SummaryDifference0.3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.